Merck KGaA以10%的利润增长击败预测,并提升了EBITDA的视野,生命科学、保健和电子学的强劲需求对此起到了推波助澜的作用。 Merck KGaA beat forecasts with 10% profit growth and raised EBITDA outlook, fueled by strong demand in life sciences, healthcare, and electronics.

默克KGaA报告第三季度业绩强,税后利增长10%,达到8.98亿欧元 (1.04亿美元),EBITDA有机增长8.8%,主要是生命科学,医疗保健和电子产品的需求. Merck KGaA reported stronger third-quarter results with a 10% rise in after-tax profit to 898 million euros ($1.04 billion) and 8.8% organic EBITDA growth, driven by demand in life sciences, healthcare, and electronics. 净销售额有机增长5.2%,达到53.2亿欧元,超过了分析师的预测。 Net sales rose 5.2% organically to 5.32 billion euros, surpassing analyst forecasts. 该公司缩小了全年展望,维持了3%的有机销售增长目标,并将欧洲BITDA公司增长指南调整为5-7%,比前2%-5%和4%-8%的范围有所增加。 The company narrowed its full-year outlook, maintaining a 3% organic sales growth target and adjusting EBITDA growth guidance to 5%–7%, up from earlier 2%–5% and 4%–8% ranges.